A state-of-the-art polygenic score for idiopathic Parkinson’s disease: benchmarking methods and impact on genetic PD carriers
Abstract
Abstract Genetic causes are identified in up to 15% of Parkinson’s disease (PD) patients; the remaining idiopathic PD (iPD) patients are attributed to polygenic risk, environmental and lifestyle factors, and interactions thereof. We applied five advanced polygenic score (PGS) tools to data from 1762 iPD patients and 4227 healthy controls of European ancestry. 5-fold cross-validation revealed a significant boost in the discriminative power of modern Bayesian methods over simpler approaches, leading to the development of a novel iPD-PGS. This score demonstrated significantly improved performance compared to existing scores, achieving an area under the curve (AUC) of 0.680 (95% confidence interval (-CI):[0.665, 0.695]). External validation confirmed its robustness. Early-onset iPD patients exhibited higher PGS values than late-onset iPD patients and healthy controls, indicating increased polygenetic burden. Applying our novel iPD-PGS to carriers of heterozygous PRKN variants and GBA1 coding risk variants suggested that penetrance in these groups is partly explained by the same polygenic alterations as observed mitigating iPD. GBA1 showed a trend toward higher discriminative potential than PRKN ( GBA1 : AUC = 0.639, 95%-CI:[0.590, 0.687]; PRKN : AUC = 0.594, 95%-CI:[0.501, 0.687]), though confidence intervals overlapped. Our study highlights the potential of advanced PGSs in PD research, particularly in identifying high-risk individuals and modifying risk in rare-variant carriers.
// Source
Authors: Sebastian Sendel, Zied Landoulsi, Katja Lohmann, Björn‐Hergen Laabs, Meike Kasten, Eva‐Juliane Vollstedt, Tatiana Usnich, Alexander Balck, Daniela Berg, Dheeraj Reddy Bobbili, Max Borsche, André Franke, Henrike Hanßen, Emadeldin Hassanin, Andrew A. Hicks, Ulrike M. Krämer, Rejko Krüger, Gregor Kuhlenbäumer, Lara Mariah Lange, Wolfgang Lieb, Brit Mollenhauer, Miriam Neis, Peter Paul Pramstaller, Jannik Prasuhn, Eva Schaeffer, Claudia Trenkwalder, Norbert Brüggemann, Ana Westenberger, Michael Wittig, Inke Regina König, Patrick May, Christine Klein, Amke Caliebe
Institutions: University of Tübingen, University of Lübeck, University Hospital Schleswig-Holstein, Christian-Albrechts-Universität zu Kiel, Eurac Research, Institute for Biomedicine, University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Paracelsus Elena Klinik Kassel